Colin Matheson Telfer

Title: Colin Matheson Telfer: Innovator in Colorectal Cancer Diagnostics

Introduction

Colin Matheson Telfer is a notable inventor based in Aberdeen, GB. He has made significant contributions to the field of cancer diagnostics, particularly in colorectal cancer. His innovative work has led to the development of important biomarkers that can aid in the diagnosis and prognosis of this disease.

Latest Patents

Colin Telfer holds a patent for "Mitochondrial stress-70 protein markers for colorectal cancer." This patent provides previously uncharacterized markers of cancers, specifically colorectal cancers, and outlines their uses as diagnostic and prognostic markers. The markers include SEQ ID NO: 1—hnRNP-K; SEQ ID NO: 2—HMG-1; SEQ ID NO: 3—proteasome subunit alpha type 1; SEQ ID NO: 4—bifunctional purine biosynthesis protein; SEQ ID NO: 5—ST11; SEQ ID NO: 6—annexin IV; SEQ ID NO: 7—60 kDa heat shock protein; SEQ ID NO: 8—T complex protein 1 beta subunit; SEQ ID NO: 9—T complex protein 1 epsilon subunit; SEQ ID NO: 10—mortalin; and SEQ ID NO: 11—TER-ATPase. His invention also provides methods and materials for using these markers in therapeutic interventions for colorectal and other cancers.

Career Highlights

Throughout his career, Colin Telfer has worked with various organizations, including Auvation Limited and the University of Aberdeen. His experience in these institutions has allowed him to further his research and contribute to advancements in cancer diagnostics.

Collaborations

Colin has collaborated with notable individuals in his field, including Graeme Ian Murray and William Thomas Melvin. These collaborations have enriched his research and expanded the impact of his work.

Conclusion

Colin Matheson Telfer is a distinguished inventor whose work in colorectal cancer diagnostics has the potential to significantly improve patient outcomes. His innovative approach to identifying cancer markers showcases the importance of research in the fight against cancer.